The financing is an extension of a Series B round completed in May that raised $26.5 million and will be used to advance and expand its research, development, and validation of biomarker-based laboratory tests.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.